Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amantadine Add-on Therapy for Motor Fluctuations in Advanced Parkinson’s Disease
2023-509728-16-00Phase 2Authorised
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing MANTADIX add-on arm with Placebo add-on arm (2 arms). Planned start Aug 2024; status: authorised.
02
Drugs
amantadine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2023-509728-16-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-509728-16-00.